Literature DB >> 7779133

Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A.

G F Ferraccioli1, L Casatta, E Bartoli, S De Vita, R Dolcetti, M Boiocchi, A Carbone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7779133     DOI： 10.1002/art.1780380624

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  8 in total

1.  Iatrogenic EBV-positive lymphoproliferative disorder with features of EBV+ mucocutaneous ulcer: evidence for concomitant TCRγ/IGH rearrangements in the Hodgkin-like neoplastic cells.

Authors:  Arianna Di Napoli; Maria Giubettini; Enrico Duranti; Antonella Ferrari; Cesare Guglielmi; Stefania Uccini; Luigi Ruco
Journal:  Virchows Arch       Date:  2011-03-12       Impact factor: 4.064

Review 2.  Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

Authors:  L Georgescu; S A Paget
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 3.  Combination therapy: the risks of infection and tumor induction.

Authors:  D E Yocum
Journal:  Springer Semin Immunopathol       Date:  2001

4.  Epstein-Barr virus-associated B-cell type non-Hodgkin's lymphoma with concurrent p53 protein expression in a rheumatoid arthritis patient treated with methotrexate.

Authors:  Yuko Hirose; Yasufumi Masaki; Jun Okada; Chang Gi Kim; Hiroshi Kawabata; Noriyoshi Ogawa; Yuji Wano; Susumu Sugai
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

5.  Reversible Epstein-Barr virus-negative lymphadenopathy and bone marrow involved by Hodgkin's lymphoma in a rheumatoid arthritis patient undergoing long-term treatment with low-dose methotrexate: a case report and review of the literature.

Authors:  Annika M Svensson; Erica R Jacobson; David Ospina; Barbara H Tindle
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

Review 6.  Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature.

Authors:  Rita Rizzi; Paola Curci; Mario Delia; Erminia Rinaldi; Antonia Chiefa; Giorgina Specchia; Vincenzo Liso
Journal:  Med Oncol       Date:  2008-05-07       Impact factor: 3.064

7.  Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types.

Authors:  Yuka Gion; Noriko Iwaki; Katsuyoshi Takata; Mai Takeuchi; Keiichiro Nishida; Yorihisa Orita; Tomoyasu Tachibana; Tadashi Yoshino; Yasuharu Sato
Journal:  Cancer Sci       Date:  2017-05-23       Impact factor: 6.716

Review 8.  Clinically important drug interactions with disease-modifying antirheumatic drugs.

Authors:  C J Haagsma
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 4.271
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.